Celltrion Pharm Incorporated operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Celltrion Pharm Incorporated with three other
companies in this sector in South Korea:
Dae Han New Pharm Co., Ltd.
sales of 130.82 billion Korean Won [US$116.16 million]
Myungmoon Pharmaceutical Company Limited
(140.14 billion Korean Won [US$124.44 million]
of which 97%
was Manufacture and Sale of Pharmaceuticals), and
Nutri Biotech Co Ltd
(136.35 billion Korean Won [US$121.08 million]
of which 100%
was Manufacture & Sales of Health Food).
Celltrion Pharm Incorporated reported sales of 135.86 billion Korean Won (US$120.64 million)
December of 2017.
increase of 29.6%
versus 2016, when the company's sales were 104.81 billion Korean Won.
Sales at Celltrion Pharm Incorporated have increased during each of the previous five years
(and since 2012, sales have increased a total of 189%).